Antidepressant Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024 – Increasing Cases of Mental Health Disorders is driving the Antidepressant Drugs Market.
Antidepressant Drugs Market is valued at USD 13.69 Billion in 2018 and expected to reach USD 15.88 Billion by 2025 with the CAGR of 2.15% over the forecast period.
Antidepressants are a type of drugs that decreases symptoms of depressive disorders by acting against chemical imbalances of neurotransmitters in brain. Antidepressants drugs are used for treatment of depressive disorder, anxiety disorders, chronic pain conditions and to manage some addictions. Antidepressants have some side effects such as dry mouth, weight gain, dizziness, headaches, sexual dysfunction and sometimes increased thoughts of suicide when taken by children, young adults and adolescents. After stopping antidepressants, a discontinuation syndrome can occur and this resembles recurrent depression. There are different classes of antidepressant drugs are available in medical industry, some of them are selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), tetracyclic antidepressant, dopamine reuptake blocker etc.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=97517&RequestType=Sample
Global antidepressant drugs market report is segmented on the basis of depressive disorder, products, regional & country level. Based upon depressive disorder, global antidepressant drugs market is classified as major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others. On the basis of products, the market is segmented in to tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, and others.
The regions covered in this antidepressant drugs market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Antidepressant Drugs is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Antidepressant Drugs Market Reports–
Global Antidepressant Drugs market report covers prominent players like Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Eli Lilly and Co., Merck & Co. Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd Teva Pharmaceutical Industries Ltd., AstraZeneca, Johnson & Johnson, and others.
Allergan Received FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=97517&RequestType=Methodology
On July 23, 2018 Allergan plc, a leading global pharmaceutical company, announced the U.S. Food and Drug Administration has approved Fast Track designation for AGN-241751, an investigational new treatment for Major Depressive Disorder (MDD). AGN-241751 is a novel, oral, rapid-acting anti-depressant that recently entered Phase 2 development. It is recognized as a potentially innovative treatment for mdd, a serious condition with persistent unmet need.
Increasing Cases of Mental Health Disorders is driving the Antidepressant Drugs Market
Increasing cases of mental health disorders globally is the main factor for the growth of antidepressant drug market, as many consumers are relying on these drugs to fight with the depression, anxiety disorder etc. Globally, the share of population with depression ranges in between 2% to 6% and older people are going through the high risk of depression comparing to other age groups. An estimation of 322 million people was under depression disorder according to WHO till 2015 and many among them are depending on these drugs for medication purpose which helps the antidepressant market to grow. In some of the anxiety disorder cases, antidepressant drugs are used. As it is the most prevalent mental health disorder with around 284 million people suffering from anxiety disorder, this creates more opportunity for the market to grow in this segment. According to the Centre for Disease Control and Prevention (CDC), the percentage of people above age 12 years using antidepressants in USA rose to 12.7% in 2011-2014. The antidepressant drugs are used in disorders such as agitation, obsessive-compulsive disorders (OCD), childhood enuresis, major depressive disorder, generalized anxiety disorder, bipolar disorder, posttraumatic stress disorder (PTSD), social anxiety disorder etc. Antidepressant drug are also used in off-label cases such as insomnia, pain and migraine. Almost 29% of antidepressant drugs are used for off-label purpose. Side effects during the medication of these drugs are the main restraining factor for antidepressant drugs market.
North America is dominating the Antidepressant Drugs Market
North America is dominating the antidepressant market due to wide use of drugs among people and large number of prescriptions along with rising disorder cases. In USA, antidepressants were the most commonly prescribed drugs in 2013 and from over 16 million long term users, around 70% are female. In Europe the antidepressant drug market is growing due to increasing number of cases along with long duration of drug treatment. For example, in England and France, the rise in antidepressants consumption has been associated with a longer duration of drug treatment. Iceland recorded the highest level of antidepressant drug consumption in 2013 with almost high prescription rate.
Asia pacific region is experiencing considerable growth rate in antidepressant drugs market due to increasing awareness of treatment procedures. According to WHO, South East Asia region have more than 86 million people who are suffering from depression. Barriers for the antidepressant drugs market in Asia Pacific region is lack of resources and trained health-care providers. For example, on an average less than 1% of government health budget is invested in mental health.
Key Benefits for Global Antidepressant Drugs Market Reports –
Global market report covers in depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Antidepressant-Drugs-Market-Size-Share-and-Forecast-to-2025/Summary
Global Antidepressant Drugs Market Segmentation –
By Depressive Disorder:
Major Depressive Disorder
Generalized Anxiety Disorder
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist and Reuptake Inhibitors
By Regional & Country Analysis
Middle East and Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Antidepressant Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Antidepressant Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Antidepressant Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Antidepressant Drugs Market Overview: Quantitative Analysis
4. Chapter – Global Antidepressant Drugs Market Analysis: By Product Type
5. Chapter – Global Antidepressant Drugs Market Analysis: By Depressive Disorder
6. Chapter – Global Antidepressant Drugs Market Analysis: By End-User
7. Chapter – Global Antidepressant Drugs Market Analysis: By Manufacturer
9. Chapter – Company Profiles
9.1. Alkermes Plc
9.2. Fluke Calibration
9.2.2. Product portfolio
9.2.3. Antidepressant Drugs Market Revenue (USD Million) and Market Share (%), 2014 – 2018
9.2.4. Antidepressant Drugs Sales Market Share (%), 2014 – 2018
9.2.5. Business strategy
9.2.6. Recent developments
9.3. Alkermes Plc
9.4. Allergan Plc
9.5. Bristol Myers Squibb Co.
9.6. Eli Lilly and Co.
9.7. GlaxoSmithKline Plc
9.8. H. Lundbeck
9.9. Eli Lilly and Co.
9.10. Merck & Co. Inc.
9.11. Pfizer Inc.
9.12. Takeda Pharmaceutical Co. Ltd
9.13. Teva Pharmaceutical Industries Ltd.
9.15. Johnson & Johnson
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org